ESR1 and breast cancer: This cholesterol metabolite is part of a group called selective estrogen receptor modulators (SERMs), and acts as an estrogen receptor agonist, enhancing the proliferation of luminal ER + BC cells (MCF-7) in vitro [116] and tumor growth in mice [117].